Standard Biotools (LAB) Non-Current Deffered Revenue (2010 - 2026)
Standard Biotools (LAB) posted quarterly Non-Current Deffered Revenue of $3.0 million for Q1 2026, down 90.74% year-over-year from $32.5 million in Q1 2025, and down 13.99% quarter-over-quarter from $3.5 million in Q4 2025.
Standard Biotools (LAB) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Non-Current Deffered Revenue for 17 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue fell 90.74% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 90.74% YoY), while the FY2025 annual figure was $3.5 million, down 89.28% from the prior year.
- Non-Current Deffered Revenue slipped to $3.0 million in Q1 2026 per LAB's latest filing, from $3.5 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $33.9 million in Q1 2024 and bottomed at $2.4 million in Q3 2025.
- Historically, Non-Current Deffered Revenue has averaged $12.4 million across 5 years, with a median of $3.8 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue soared 840.76% — and 2025, when it tumbled 92.76%.
- Standard Biotools' Non-Current Deffered Revenue stood at $3.8 million in 2022, then slipped by 7.76% to $3.5 million in 2023, then surged by 828.24% to $32.7 million in 2024, then slumped by 89.28% to $3.5 million in 2025, then declined by 13.99% to $3.0 million in 2026.
- Business Quant data shows LAB's Non-Current Deffered Revenue at $3.0 million in Q1 2026, $3.5 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn | 3.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Mn |
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 32.55 Mn |
| Dec 31, 2024 | 32.67 Mn |
| Sep 30, 2024 | 32.68 Mn |
| Jun 30, 2024 | 33.40 Mn |
| Mar 31, 2024 | 33.85 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 3.82 Mn |
| Sep 30, 2022 | 4.43 Mn |
| Jun 30, 2022 | 5.06 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | 5.97 Mn |
| Sep 30, 2021 | 6.03 Mn |